Aims To assess the pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of the glucagon receptor antagonist PF ‐06291874 in patients with type 2 diabetes mellitus ( T2DM ). Methods Patients were randomized to oral PF ‐06291874 or placebo on a background of eithe…